Analysis of European Medicines Agency’s COVID-19 Vaccine Information Materials in EU and Regional Context
Preprint
- 14 August 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The COVID-19 pandemic made it harder to communicate accurate information about vaccines because of the spread of misinformation. The European Medicines Agency (EMA) tried to reas-sure the public by communicating about the development and approval of COVID-19 vaccines. They surveyed patients/consumers, healthcare professional organizations, and individual stake-holders to see if their core information materials were informative and well understood. They also asked about the public's preferred communication channels. The surveys showed that indi-vidual patients/consumers generally prefer to get information about COVID-19 vaccines from the internet or mass media. Organizations and individual healthcare professionals prefer to get in-formation from national and international health authorities' sources. This supports EMA's ap-proach of using media, stakeholder engagement, and web-based formats to communicate about COVID-19 vaccines. Both at the EU and local levels, participants had a good understanding of the key messages from regulators and found the materials useful and relevant. However, some im-provements were recommended to the visuals, texts, and dissemination formats. These recom-mendations were generally consistent in both contexts. User-testing of proactive communication materials aimed at prebunking misinformation during a public health crisis helps to ensure that users understand the development and safety safeguards of novel vaccine technologies. This in-formation can then be used as a basis for evidence-based communication activities by regulators and public health bodies in an emergency context.Keywords
All Related Versions
- Version 1, 2023-08-14, Preprints
- Published version: Vaccines, 11 (10), 1616.
This publication has 21 references indexed in Scilit:
- Long COVID: major findings, mechanisms and recommendationsNature Reviews Microbiology, 2023
- An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomesHealth Policy and Technology, 2021
- Shaping EU medicines regulation in the post COVID-19 eraThe Lancet Regional Health - Europe, 2021
- Determinants of information diffusion in online communication on vaccination: The benefits of visual displaysVaccine, 2021
- Exploring the Gap Between Excess Mortality and COVID-19 Deaths in 67 CountriesJAMA Network Open, 2021
- The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccinesThe Lancet, 2021
- Five rules for evidence communicationNature, 2020
- SARS-CoV-2 vaccines in developmentNature, 2020
- A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisationThe Lancet Infectious Diseases, 2020
- Developing Covid-19 Vaccines at Pandemic SpeedNew England Journal of Medicine, 2020